ORENCIA
Drug timelines are a Plus or Pro feature.
83 regulatory and trial events tracked for ORENCIA, covering 2006-12-12 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation [Phase 1]